Compare BKE & INSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BKE | INSP |
|---|---|---|
| Founded | 1948 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Clothing/Shoe/Accessory Stores | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.2B | 2.2B |
| IPO Year | 1996 | 2018 |
| Metric | BKE | INSP |
|---|---|---|
| Price | $43.57 | $70.80 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 17 |
| Target Price | N/A | ★ $62.80 |
| AVG Volume (30 Days) | 451.0K | ★ 870.3K |
| Earning Date | 11-20-2026 | 11-02-2026 |
| Dividend Yield | ★ 3.26% | N/A |
| EPS Growth | 6.43 | ★ 179.43 |
| EPS | ★ 1.79 | N/A |
| Revenue | ★ $1,297,835,000.00 | $82,050,000.00 |
| Revenue This Year | $5.47 | N/A |
| Revenue Next Year | $3.97 | $3.88 |
| P/E Ratio | $23.85 | ★ N/A |
| Revenue Growth | 6.58 | ★ 62.18 |
| 52 Week Low | $39.44 | $38.91 |
| 52 Week High | $58.52 | $147.03 |
| Indicator | BKE | INSP |
|---|---|---|
| Relative Strength Index (RSI) | 58.77 | 55.82 |
| Support Level | $42.15 | $68.13 |
| Resistance Level | $43.88 | $78.80 |
| Average True Range (ATR) | 0.90 | 3.64 |
| MACD | 0.37 | -0.68 |
| Stochastic Oscillator | 92.84 | 25.68 |
Buckle Inc is a retailer of casual apparel, footwear, and accessories. The company retails medium to affordable priced casual apparel, footwear, and accessories for fashion-conscious young men and women. It retails under the brand names 'Buckle' and 'The Buckle'. Buckle markets a wide selection of mostly brand-name casual apparel including denim, other casual bottoms, tops, sportswear, outerwear, accessories, and footwear.
Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and All other countries wherein, it generates a majority of its revenue from the United States. Its segment revenues are derived from the sales of its product, the Inspire system, to hospitals and ambulatory surgery centers in the U.S. and in selected countries in Europe and the Asia Pacific region.